Compile Data Set for Download or QSAR
Report error Found 13 Enz. Inhib. hit(s) with all data for entry = 6735
TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM150268(US8980954, 6p)
Affinity DataIC50: 150nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent

TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM150266(US8980954, 4cc)
Affinity DataIC50: 150nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent

TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM150267(US8980954, 4k)
Affinity DataIC50: 300nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent

TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM150264(US8980954, 6cc)
Affinity DataIC50: 500nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent

TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM50440270(CHEMBL215432)
Affinity DataIC50: 600nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent

TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM150265(US8980954, 6r)
Affinity DataIC50: 600nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent

TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM150272(US8980954, 6i)
Affinity DataIC50: 800nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent

TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM150273(US8980954, 6d)
Affinity DataIC50: 900nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent

TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM150269(US8980954, 6h)
Affinity DataIC50: 1.00E+3nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent

TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM150270(US8980954, 6n)
Affinity DataIC50: 1.10E+3nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent

TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM150274(US8980954, 8e)
Affinity DataIC50: 1.30E+3nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent

TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM150271(US8980954, 6j)
Affinity DataIC50: 1.50E+3nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent

TargetTranscription factor p65(Human)
Stc.Unm

US Patent
LigandPNGBDBM23926(5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol...)
Affinity DataIC50: 2.00E+4nMAssay Description:The actual target(s) whereby the most active substituted trans-stilbenes inhibit the TNFα-induced activation of NF-κB remains to be identif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2015
Entry Details
US Patent